{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:25:09Z","timestamp":1793413509815,"version":"4.5.0"},"reference-count":299,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.trim.2023.101798","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:43:42Z","timestamp":1675046622000},"page":"101798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Infections after organ transplantation and immune response"],"prefix":"10.1016","volume":"77","author":[{"given":"Amir","family":"Elalouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2023.101798_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12871-019-0704-z","article-title":"Organ transplantation in the modern era","volume":"19","author":"Bezinover","year":"2019","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.trim.2023.101798_bb0010","first-page":"2","article-title":"Ancient myth, modern reality: a brief history of transplantation","volume":"24","author":"Bergan","year":"1997","journal-title":"J. Biocommun."},{"key":"10.1016\/j.trim.2023.101798_bb0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/089419301300343282","article-title":"Organ transplantation: from myth to reality","volume":"14","author":"Shayan","year":"2001","journal-title":"J. Investig. Surg."},{"key":"10.1016\/j.trim.2023.101798_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ccc.2008.12.001","article-title":"History of solid organ transplantation and organ donation","volume":"25","author":"Linden","year":"2009","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.trim.2023.101798_bb0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014977","article-title":"Historical overview of transplantation","volume":"3","author":"Barker","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.trim.2023.101798_bb0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/08998280.2021.1985889","article-title":"The history of organ transplantation","volume":"35","author":"Nordham","year":"2022","journal-title":"Baylor Univ. Med. Cent. Proc."},{"key":"10.1016\/j.trim.2023.101798_bb0035","author":"Organ Donation Statistics"},{"key":"10.1016\/j.trim.2023.101798_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.29245\/2578-3009\/2019\/4.1178","article-title":"Immunosuppressive drugs in organ transplantation to prevent allograft rejection: mode of action and side effects","volume":"3","author":"Claeys","year":"2019","journal-title":"J. Immunol. Sci."},{"key":"10.1016\/j.trim.2023.101798_bb0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/164_2019_331","article-title":"Immunosuppressants in organ transplantation","volume":"261","author":"T\u00f6nshoff","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.trim.2023.101798_bb0050","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression,\u201d","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0055","doi-asserted-by":"crossref","first-page":"E159","DOI":"10.1093\/cid\/ciz1113","article-title":"Burden and timeline of infectious diseases in the first year after solid organ transplantation in the swiss transplant cohort study","volume":"71","author":"Van Delden","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0060","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.trim.2023.101798_bb0065","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"10.1016\/j.trim.2023.101798_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","article-title":"Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review","volume":"26","author":"Falagas","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.trim.2023.101798_bb0075","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0080","series-title":"Mol. Biol. Cell","article-title":"The adaptive immune system in molecular biology of the cell","author":"B","year":"2002"},{"key":"10.1016\/j.trim.2023.101798_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5986740","article-title":"Kidney transplantation: the challenge of human leukocyte antigen and its therapeutic strategies","volume":"2018","author":"Alelign","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.trim.2023.101798_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/imr.13087","article-title":"Immunity at maternal\u2013fetal interface: KIR\/HLA (Allo)recognition*","volume":"308","author":"Alexandrova","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.trim.2023.101798_bb0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/ajt.16812","article-title":"Rate of recipient-derived alveolar macrophage development and major histocompatibility complex cross-decoration after lung transplantation in humans","volume":"22","author":"Snyder","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/TP.0000000000003969","article-title":"Antibody responses to minor histocompatibility antigens after solid organ transplantation","volume":"106","author":"Zorn","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0105","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/MOT.0b013e328309ee31","article-title":"Pathways of major histocompatibility complex allorecognition","volume":"13","author":"Afzali","year":"2008","journal-title":"Curr. Opin. Organ Transplant"},{"key":"10.1016\/j.trim.2023.101798_bb0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MOT.0000000000000263","article-title":"Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms","volume":"21","author":"Lin","year":"2016","journal-title":"Curr. Opin. Organ Transplant"},{"key":"10.1016\/j.trim.2023.101798_bb0115","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.3389\/fimmu.2021.667834","article-title":"The impact of inflammation on the immune responses to transplantation: tolerance or rejection?","volume":"12","author":"Ravindranath","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb0120","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3390\/cells10051155","article-title":"Shaping of t cell functions by trogocytosis","volume":"10","author":"Nakayama","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.trim.2023.101798_bb0125","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","article-title":"Allorecognition by T lymphocytes and allograft rejection","volume":"7","author":"Marino","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb0130","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.3389\/fimmu.2020.586168","article-title":"HLA class I knockout converts allogeneic primary NK cells into suitable effectors for \u201coff-the-shelf\u201d immunotherapy","volume":"11","author":"Hoerster","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/phar.2481","article-title":"Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management","volume":"41","author":"Pilch","year":"2021","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.trim.2023.101798_bb0140","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/08923973.2021.1966033","article-title":"Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs","volume":"43","author":"Parlakpinar","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.trim.2023.101798_bb0145","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.3390\/ijms20184544","article-title":"The role of major histocompatibility complex in organ transplantation- donor specific anti-major histocompatibility complex antibodies analysis goes to the next stage","volume":"20","author":"Nakamura","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2023.101798_bb0150","first-page":"8187","article-title":"Recent advances in CD8+ regulatory t cell research (review)","volume":"15","author":"Yu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.trim.2023.101798_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jare.2021.03.014","article-title":"Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4+ and CD8+ T cells","volume":"35","author":"Sun","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.trim.2023.101798_bb0160","series-title":"Mol. Biol. Cell","first-page":"1569","article-title":"T cells and MHC proteins","author":"Alberts","year":"2008"},{"key":"10.1016\/j.trim.2023.101798_bb0165","series-title":"Biomater. Sci. An Introd. to Mater","first-page":"512","article-title":"Innate and adaptive immunity: The immune response to foreign materials","author":"Mitchell","year":"2013"},{"key":"10.1016\/j.trim.2023.101798_bb0170","article-title":"B-cell activation by armed helper T cells - Immunobiology","author":"Janeway","year":"2001","journal-title":"Immunobiol. Immune Syst. Heal. Dis. 5th ed."},{"key":"10.1016\/j.trim.2023.101798_bb0175","first-page":"1","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trim.2023.101798_bb0180","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/HJH.0000000000002456","article-title":"Adaptive immune disorders in hypertension and heart failure: focusing on T-cell subset activation and clinical implications","volume":"38","author":"Rai","year":"2020","journal-title":"J. Hypertens."},{"key":"10.1016\/j.trim.2023.101798_bb0185","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fphar.2018.00642","article-title":"Molecular mechanisms of T cells activation by dendritic cells in autoimmune diseases","volume":"9","author":"Tai","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.trim.2023.101798_bb0190","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.kint.2021.11.029","article-title":"Allorecognition and the spectrum of kidney transplant rejection","volume":"101","author":"Callemeyn","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2023.101798_bb0195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nri.2015.1","article-title":"Regulatory T cell memory","volume":"16","author":"Rosenblum","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb0200","series-title":"Renal Transplantation Rejection","first-page":"1","volume":"01","author":"Naik","year":"2020"},{"key":"10.1016\/j.trim.2023.101798_bb0205","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3390\/ijms23031592","article-title":"Implantable immunosuppressant delivery to prevent rejection in transplantation","volume":"23","author":"Anggelia","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2023.101798_bb0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cnur.2015.10.008","article-title":"Immunosuppressive therapy in transplantation","volume":"51","author":"Allison","year":"2016","journal-title":"Nurs. Clin. North Am."},{"key":"10.1016\/j.trim.2023.101798_bb0215","series-title":"Adv. Exp. Med. Biol","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-981-32-9717-3_10","article-title":"Costimulation blockade in transplantation","author":"Yeung","year":"2019"},{"key":"10.1016\/j.trim.2023.101798_bb0220","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CNQ.0000000000000117","article-title":"Immunosuppression in solid-organ transplantation essentials and practical tips","volume":"39","author":"Jasiak","year":"2016","journal-title":"Crit. Care Nurs. Q"},{"key":"10.1016\/j.trim.2023.101798_bb0225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physiol.00021.2019","article-title":"Adipose tissue-derived stem cells: immunomodulatory effects and therapeutic potential","volume":"35","author":"Al-Ghadban","year":"2020","journal-title":"Physiology."},{"key":"10.1016\/j.trim.2023.101798_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3057624","article-title":"Mesenchymal stem cell-based immunomodulation: properties and clinical application","volume":"2018","author":"Wang","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.trim.2023.101798_bb0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/TP.0000000000001452","article-title":"Interleukin-6, a cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade","volume":"101","author":"Jordan","year":"2017","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0240","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11892-013-0401-0","article-title":"Anti-inflammatory strategies to enhance islet engraftment and survival","volume":"13","author":"Citro","year":"2013","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.trim.2023.101798_bb0245","series-title":"Neuroimaging Pharmacopoeia","first-page":"177","article-title":"Calcineurin inhibitors","author":"Shah","year":"2015"},{"key":"10.1016\/j.trim.2023.101798_bb0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2220\/biomedres.39.131","article-title":"Effects of the calcineurin inhibitors cyclosporine and tacrolimus on bone metabolism in rats","volume":"39","author":"Kanda","year":"2018","journal-title":"Biomed. Res."},{"key":"10.1016\/j.trim.2023.101798_bb0255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41401-018-0070-2","article-title":"Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation","volume":"40","author":"Fu","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.trim.2023.101798_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14743","article-title":"The use of non-transplant biologics in solid organ transplant recipients: a practical review for the frontline clinician","volume":"36","author":"Szczepanik","year":"2022","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semnephrol.2022.01.001","article-title":"Immunosuppression in the age of precision medicine","volume":"42","author":"Gabardi","year":"2022","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0270","doi-asserted-by":"crossref","DOI":"10.1080\/14728214.2022.2091131","article-title":"Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials","author":"Mayer","year":"2022","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.trim.2023.101798_bb0275","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/lt.26387","article-title":"Sirolimus or everolimus improves survival after liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"28","author":"Yan","year":"2022","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0280","series-title":"Pharmacol. Immunosuppr","first-page":"53","article-title":"Mechanistic Target of Rapamycin (mTOR) inhibitors","author":"Wang","year":"2021"},{"key":"10.1016\/j.trim.2023.101798_bb0285","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/08820538.2021.1966059","article-title":"Systemic immunosuppression in cornea and ocular surface disorders: a ready reckoner for ophthalmologists","volume":"37","author":"Kate","year":"2022","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.trim.2023.101798_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2022.06.007","article-title":"Immunosuppressive drugs in liver transplant: an insight","author":"Panackel","year":"2022","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.trim.2023.101798_bb0295","series-title":"Pharmacol. Immunosuppr","first-page":"73","article-title":"Corticosteroids in immunosuppression","author":"Marzbani","year":"2022"},{"key":"10.1016\/j.trim.2023.101798_bb0300","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40272-022-00512-3","article-title":"Immunosuppression regimens for intestinal transplantation in children","volume":"24","author":"Raghu","year":"2022","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.trim.2023.101798_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235743","article-title":"Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits Bcell IL-6 production","volume":"15","author":"Von Borstel","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2023.101798_bb0310","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-018-3929-z","article-title":"Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome","volume":"34","author":"Schijvens","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0315","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.embor.7400775","article-title":"Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN","volume":"7","author":"L\u00f6wenberg","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.trim.2023.101798_bb0320","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cld.2016.12.007","article-title":"Management of Immunosuppression in liver transplantation","volume":"21","author":"Dhanasekaran","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0325","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14077","article-title":"Induction and maintenance immunosuppression in pediatric kidney transplantation\u2014advances and controversies","volume":"25","author":"Balani","year":"2021","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0330","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmi.2022.02.005","article-title":"An overview of COVID-19 in solid organ transplantation","volume":"28","author":"Bartelt","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.trim.2023.101798_bb0335","first-page":"29","article-title":"Immunosuppression in kidney transplantation: a way between efficacy and toxicity","volume":"34","author":"Casati","year":"2017","journal-title":"G. Ital. Nefrol."},{"key":"10.1016\/j.trim.2023.101798_bb0340","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00134-018-05515-8","article-title":"Initial immunosuppression and managing rejection","volume":"45","author":"Fuehner","year":"2019","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.trim.2023.101798_bb0345","series-title":"Chronic Kidney Dis. - Beyond Basics","article-title":"Immunosuppressive drug management in kidney transplant recipients","author":"Dekeyser","year":"2022"},{"key":"10.1016\/j.trim.2023.101798_bb0350","series-title":"Evaluation for Infection before Solid Organ Transplantation Author, UpToDate","first-page":"1","author":"Fishman","year":"2022"},{"key":"10.1016\/j.trim.2023.101798_bb0355","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1469-0691.12557","article-title":"Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections","volume":"20","author":"Len","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.trim.2023.101798_bb0360","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1111\/ajt.13317","article-title":"Outcome of transplantation using organs from donors infected or colonized with carbapenem-resistant gram-negative bacteria","volume":"15","author":"Mularoni","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0365","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/lt.24486","article-title":"Multidrug-resistant organisms in liver transplant: mitigating risk and managing infections","volume":"22","author":"Hand","year":"2016","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0370","series-title":"Pharmacol. Immunosuppr","first-page":"287","article-title":"Adverse effects of immunosuppression: Infections","author":"Handley","year":"2021"},{"key":"10.1016\/j.trim.2023.101798_bb0375","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/cid\/cix1008","article-title":"Evaluation of a novel global immunity assay to predict infection in organ transplant recipients","volume":"66","author":"Mian","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0380","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00134-019-05597-y","article-title":"Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients","volume":"45","author":"Timsit","year":"2019","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.trim.2023.101798_bb0385","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/JCM.03336-15","article-title":"Multicenter evaluation of whole-blood Epstein-Barr viral load standardization using the who international standard","volume":"54","author":"Semenova","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.trim.2023.101798_bb0390","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cid\/ciw370","article-title":"Are we there yet? Impact of the first international standard for cytomegalovirus DNA on the harmonization of results reported on plasma samples","volume":"63","author":"Preiksaitis","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0395","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-0012.2009.00976.x","article-title":"CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study","volume":"24","author":"Sund","year":"2010","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0400","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/lt.23991","article-title":"Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation","volume":"20","author":"Nierenberg","year":"2014","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0405","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/lt.21833","article-title":"Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation","volume":"15","author":"Fern\u00e1ndez-Ruiz","year":"2009","journal-title":"Liver Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0410","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/tri.12321","article-title":"Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation","volume":"27","author":"Fern\u00e1ndez-Ruiz","year":"2014","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2023.101798_bb0415","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/TP.0b013e318239e90c","article-title":"Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients","volume":"93","author":"Calarota","year":"2012","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0420","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/tid.12284","article-title":"Evaluation of an immunological score to assess the risk of severe infection in heart recipients","volume":"16","author":"Sarmiento","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0425","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13301","article-title":"Assessment of immunodeficiency scoring index performance in enterovirus\/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"P\u00e9rez","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0430","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3904\/kjim.2017.318","article-title":"Diagnostic usefulness of the cytomegalovirus (CMV)-specific T cell-based assay for predicting CMV infection after kidney transplant","volume":"35","author":"Kim","year":"2020","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.trim.2023.101798_bb0435","series-title":"Infections in Solid-Organ Transplant Recipients","author":"Singh","year":"2023"},{"key":"10.1016\/j.trim.2023.101798_bb0440","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/clpt.2011.90","article-title":"Management of infectious complications in solid-organ transplant recipients","volume":"90","author":"Grim","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.trim.2023.101798_bb0445","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0213-005X(12)70077-0","article-title":"Epidemiology and risk factors of infections after solid organ transplantation","volume":"30","author":"Mu\u00f1oz","year":"2012","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.trim.2023.101798_bb0450","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.suc.2006.06.005","article-title":"Infections complicating solid organ transplantation","volume":"86","author":"Fischer","year":"2006","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.trim.2023.101798_bb0455","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.15971020","article-title":"Long-term infectious complications of kidney transplantation","volume":"17","author":"Agrawal","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0460","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz037","article-title":"Infectious complications after umbilical cord blood transplantation for hematological malignancy","volume":"6","author":"Linder","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0465","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients\u2014guidelines of the American society of transplantation infectious diseases community of practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0470","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1600-6143.2006.01694.x","article-title":"Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group","volume":"7","author":"San Juan","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0475","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/820621","article-title":"Viral infection in renal transplant recipients","volume":"2012","author":"Cukuranovic","year":"2012","journal-title":"Sci. World J."},{"key":"10.1016\/j.trim.2023.101798_bb0480","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3389\/fped.2021.765546","article-title":"Lower CMV and EBV exposure in children with Kawasaki disease suggests an under-challenged immune system","volume":"9","author":"van Stijn","year":"2021","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.trim.2023.101798_bb0485","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41423-021-00774-w","article-title":"Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects","volume":"19","author":"Zheng","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb0490","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5501\/wjv.v1.i6.150","article-title":"Evaluation of virus-specific cellular immune response in transplant patients","volume":"1","author":"Costa","year":"2012","journal-title":"World J. Virol."},{"key":"10.1016\/j.trim.2023.101798_bb0495","first-page":"304","article-title":"Recurrence of hepatitis C after liver transplantation","volume":"26","author":"Vinaixa","year":"2013","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.trim.2023.101798_bb0500","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ebiom.2019.07.043","article-title":"Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality","volume":"46","author":"Wang","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.trim.2023.101798_bb0505","first-page":"140","article-title":"Management of hepatitis C post-liver transplantation: a comprehensive review","volume":"3","author":"Mitchell","year":"2015","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.trim.2023.101798_bb0510","first-page":"211","article-title":"Hepatitis C and liver transplantation","volume":"13","author":"Tsoulfas","year":"2009","journal-title":"Hippokratia."},{"key":"10.1016\/j.trim.2023.101798_bb0515","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4254\/wjh.v5.i5.237","article-title":"Strategies to reduce hepatitis C virus recurrence after liver transplantation","volume":"5","author":"Ciria","year":"2013","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.trim.2023.101798_bb0520","first-page":"214","article-title":"Hepatitis C virus and liver transplantation","volume":"13","author":"Bhamidimarri","year":"2017","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.trim.2023.101798_bb0525","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12072-021-10170-1","article-title":"The Asian Pacific Association for the study of the liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis","volume":"15","author":"Wang","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.trim.2023.101798_bb0530","first-page":"454","article-title":"Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation","volume":"29","author":"Hori","year":"2016","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.trim.2023.101798_bb0535","doi-asserted-by":"crossref","first-page":"550","DOI":"10.29271\/jcpsp.2020.05.550","article-title":"Seroprevalence of hepatitis C virus (HCV) and hepatitis B virus (HBV) in district Vehari, Pakistan","volume":"30","author":"Ahmed","year":"2020","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.trim.2023.101798_bb0540","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.2215\/CJN.04410512","article-title":"Common infections in kidney transplant recipients","volume":"7","author":"Karuthu","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2011\/180201","article-title":"Dilemma of HCV infection in renal transplant recipients","volume":"2011","author":"Gheith","year":"2011","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0550","article-title":"Renal transplantation in patients with hepatitis C virus antibody. A long national experience","volume":"3","author":"Morales","year":"2010","journal-title":"NDT Plus"},{"key":"10.1016\/j.trim.2023.101798_bb0555","first-page":"189","article-title":"Hepatitis C virus transmission at an outpatient hemodialysis unit\u2014New York, 2001\u20132008","volume":"58","author":"Hallack","year":"2009","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.trim.2023.101798_bb0560","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13598","article-title":"Use of HCV Ab+\/NAT\u2212 donors in HCV na\u00efve renal transplant recipients to expand the kidney donor pool","volume":"33","author":"Dao","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0565","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jmv.1890440109","article-title":"Hepatitis C virus infections in transplant patients: serological and virological investigations","volume":"44","author":"Maple","year":"1994","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.trim.2023.101798_bb0570","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/00007890-199804150-00012","article-title":"Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features","volume":"65","author":"Rostaing","year":"1998","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0575","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/17.1.129","article-title":"Severe evolution of chronic hepatitis C in renal transplantation: a case control study","volume":"17","author":"Zylberberg","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0580","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1600-6143.2005.00918.x","article-title":"Natural history of hepatitis C virus-related liver fibrosis after renal transplantation","volume":"5","author":"Kamar","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0585","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/ajt.14640","article-title":"Clostridium difficile infection is associated with graft loss in solid organ transplant recipients","volume":"18","author":"Cusini","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124483","article-title":"Prevalence of clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies","volume":"10","author":"Paudel","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2023.101798_bb0595","doi-asserted-by":"crossref","first-page":"E4090","DOI":"10.1093\/cid\/ciaa1097","article-title":"Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study","volume":"73","author":"Kates","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0600","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1111\/j.1600-6143.2009.02902.x","article-title":"Viral hepatitis in solid organ transplant recipients","volume":"9","author":"Levitsky","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0605","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"Special issue: KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Fornairon","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0610","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ki.2009.377","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary","volume":"77","author":"Kasiske","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2023.101798_bb0615","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00007890-200102150-00008","article-title":"Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence","volume":"71","author":"Han","year":"2001","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0620","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/jhep.2002.36156","article-title":"Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients","volume":"36","author":"Chan","year":"2002","journal-title":"Hepatology."},{"key":"10.1016\/j.trim.2023.101798_bb0625","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.23327","article-title":"Entecavir treatment for up to 5 years in patients with hepatitis b e antigen-positive chronic hepatitis B","volume":"51","author":"Chang","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.trim.2023.101798_bb0630","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1681\/ASN.2015010059","article-title":"Kidney transplantation in HIV-infected recipients: encouraging outcomes, but registry data are no longer enough","volume":"26","author":"Wright","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0635","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13499","article-title":"Solid organ transplantation in the HIV-infected patient: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Blumberg","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0640","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1432-2277.2007.00483.x","article-title":"Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation","volume":"20","author":"Ciuffreda","year":"2007","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2023.101798_bb0645","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2006.01238.x","article-title":"Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients","volume":"6","author":"Carter","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0650","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ki.2010.545","article-title":"Renal transplantation in HIV-infected patients: 2010 update","volume":"79","author":"Trullas","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2023.101798_bb0655","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trre.2016.12.001","article-title":"Epstein\u2013Barr virus and renal transplantation","volume":"31","author":"Le","year":"2017","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.trim.2023.101798_bb0660","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0665","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/ajt.12009","article-title":"Subclinical Epstein-Barr virus Viremia among adult renal transplant recipients: incidence and consequences","volume":"13","author":"Bamoulid","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0670","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0675","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","article-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?","volume":"79","author":"Ghobrial","year":"2005","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0680","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ajt.14020","article-title":"The role of antiviral prophylaxis for the prevention of Epstein\u2013Barr Virus\u2013associated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review","volume":"17","author":"AlDabbagh","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0685","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7182\/pit2013122","article-title":"Risk evaluation and mitigation strategies: a focus on belatacept","volume":"23","author":"Sam","year":"2013","journal-title":"Prog. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0690","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.blre.2003.12.002","article-title":"Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease","volume":"18","author":"Burns","year":"2004","journal-title":"Blood Rev."},{"key":"10.1016\/j.trim.2023.101798_bb0695","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2215\/CJN.03790417","article-title":"A French cohort study of kidney retransplantation after post-transplant lymphoproliferative disorders","volume":"12","author":"Caillard","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0700","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French registry","volume":"6","author":"Caillard","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0705","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.2215\/CJN.02900707","article-title":"Viral infection after renal transplantation: surveillance and management","volume":"3","author":"Weikert","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0710","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2012.09.002","article-title":"Gut microbiota, immune development and function","volume":"69","author":"Bengmark","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.trim.2023.101798_bb0715","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1600-6143.2005.01115.x","article-title":"Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients","volume":"5","author":"Funch","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0720","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0725","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ajt.16132","article-title":"CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept","volume":"21","author":"Karadkhele","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0730","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/ajt.15315","article-title":"A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients","volume":"19","author":"Kumar","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0735","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0740","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2009.02861.x","article-title":"Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients","volume":"10","author":"Eid","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0745","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/hep.1840120119","article-title":"Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: role of immunostaining, dna hybridization and culture of hepatic tissue","volume":"12","author":"Paya","year":"1990","journal-title":"Hepatology."},{"key":"10.1016\/j.trim.2023.101798_bb0750","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.trim.2023.101798_bb0755","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1111\/ajt.16578","article-title":"COVID-19 mortality among kidney transplant candidates is strongly associated with social determinants of health","volume":"21","author":"Schold","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0760","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0765","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1681\/ASN.2020050686","article-title":"Multicenter study to transplant hepatitis C-infected kidneys (mythic): an open-label study of combined glecaprevir and pibrentasvir to treat recipients of transplanted kidneys from deceased donors with hepatitis c virus infection","volume":"31","author":"Sise","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0770","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/tid.12203","article-title":"Nosocomial infections within the first month of solid organ transplantation","volume":"16","author":"Dorschner","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0775","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13514","article-title":"Viral hepatitis: guidelines by the American society of transplantation infectious disease community of practice","volume":"33","author":"Te","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0780","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/TP.0000000000000030","article-title":"Delayed-onset cytomegalovirus disease coded during hospital readmission after kidney transplantation","volume":"98","author":"Santos","year":"2014","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000363","article-title":"Seroepidemiology of human polyomaviruses","volume":"5","author":"Kean","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.trim.2023.101798_bb0790","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","article-title":"Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors","volume":"199","author":"Egli","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0795","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-020-05292-0","article-title":"BK virus-associated nephropathy in a lung transplant patient: case report and literature review","volume":"20","author":"Crowhurst","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0800","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2023.101798_bb0805","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2215\/CJN.13221216","article-title":"CMV and BKPyV infections in renal transplant recipients receiving an mtor inhibitor\u2013based regimen versus a cni-based regimen: a systematic review and meta-analysis of randomized, controlled trials","volume":"12","author":"Mallat","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0810","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy","volume":"10","author":"Schaub","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0815","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1681\/ASN.2017050477","article-title":"The Banff working group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations","volume":"29","author":"Nickeleit","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0820","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0825","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2020.100565","article-title":"Leflunomide in the treatment of BK polyomavirus associated nephropathy in kidney transplanted patients \u2013 a systematic review","volume":"34","author":"Schneidewind","year":"2020","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.trim.2023.101798_bb0835","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2215\/CJN.04230413","article-title":"Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial","volume":"9","author":"Lee","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0840","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13399","article-title":"T-cell adoptive immunotherapy for BK nephropathy in renal transplantation","volume":"22","author":"Jahan","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0845","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/ajt.15723","article-title":"Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents","volume":"20","author":"Leeaphorn","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0850","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-6143.2005.01171.x","article-title":"Retransplantation after polyomavirus-associated nephropathy: just do it?","volume":"6","author":"Hirsch","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0855","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/TP.0b013e31822d08c1","article-title":"Results of repeat renal transplantation after graft loss from BK virus nephropathy","volume":"92","author":"Geetha","year":"2011","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0860","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-6143.2009.02904.x","article-title":"BK virus in solid organ transplant recipients","volume":"9","author":"Hirsch","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0865","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.humpath.2005.08.009","article-title":"Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods","volume":"36","author":"Drachenberg","year":"2005","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.trim.2023.101798_bb0870","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/TP.0b013e31817c6447","article-title":"Epidemiology of BK virus in renal allograft recipients: independent risk factors for bk virus replication","volume":"86","author":"Dadhania","year":"2008","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0875","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0880","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.ki.5000040","article-title":"BK virus nephritis after renal transplantation","volume":"69","author":"Hariharan","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2023.101798_bb0885","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1523-1755.2003.00103.x","article-title":"Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy","volume":"64","author":"Buehrig","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2023.101798_bb0890","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.tp.0000181149.76113.50","article-title":"Treatment of renal allograft polyoma BK virus infection with leflunomide","volume":"81","author":"Josephson","year":"2006","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb0895","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1432-2277.2007.00523.x","article-title":"Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation","volume":"20","author":"Faguer","year":"2007","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2023.101798_bb0900","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJMra0804575","article-title":"Norovirus gastroenteritis","volume":"361","author":"Glass","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2023.101798_bb0905","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/tid.12212","article-title":"Diarrhea caused by viruses in transplant recipients","volume":"16","author":"Lee","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0910","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13550","article-title":"Diagnosis and management of diarrhea in solid-organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Angarone","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0915","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/cid\/ciu880","article-title":"Diagnostic yields in solid organ transplant recipients admitted with diarrhea","volume":"60","author":"Echenique","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0920","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jcv.2014.08.004","article-title":"Prospective study on norovirus infection among allogeneic stem cell transplant recipients: prolonged viral excretion and viral RNA in the blood","volume":"61","author":"Lemes","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.trim.2023.101798_bb0925","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/653939","article-title":"Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution","volume":"51","author":"Schorn","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0930","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12185-015-1804-2","article-title":"Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography","volume":"102","author":"Ueda","year":"2015","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.trim.2023.101798_bb0935","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/ajt.13227","article-title":"Noroviruses as a cause of diarrhea in immunocompromised pediatric hematopoietic stem cell and solid organ transplant recipients","volume":"15","author":"Ye","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0940","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1399-3046.2011.01556.x","article-title":"Is there a role for oral human immunoglobulin in the treatment for norovirus enteritis in immunocompromised patients?","volume":"15","author":"Florescu","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0945","series-title":"Biology of Blood and Marrow Transplantation","author":"Nitazoxanide Is Effective Therapy for Norovirus Gastroenteritis after Chemotherapy and Hematopoietic Stem Cell Transplantation (HSCT)","year":"2023"},{"key":"10.1016\/j.trim.2023.101798_bb0950","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/TP.0000000000003523","article-title":"COVID-19 and solid organ transplantation: a review article","author":"Azzi","year":"2021","journal-title":"Transplantation."},{"issue":"2","key":"10.1016\/j.trim.2023.101798_bb0955","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.34067\/KID.0002532021","article-title":"Risks and benefits of kidney transplantation during the COVID-19 pandemic: transplant or not transplant?","volume":"360","author":"Ajaimy","year":"2021","journal-title":"Kidney"},{"key":"10.1016\/j.trim.2023.101798_bb0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-022-02784-w","article-title":"COVID-19 in kidney transplant recipients: a multicenter experience from the first two waves of pandemic","volume":"23","author":"Demir","year":"2022","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb0965","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/tri.13840","article-title":"The impact of COVID-19 on kidney transplantation and the kidney transplant recipient \u2013 one year into the pandemic","volume":"34","author":"Khairallah","year":"2021","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2023.101798_bb0970","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13511","article-title":"RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Manuel","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb0975","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/ajt.14042","article-title":"Epidemiology and immediate indirect effects of respiratory viruses in lung transplant recipients: a 5-year prospective study","volume":"17","author":"Peghin","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0980","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated aspergillosis in critically ill patients","volume":"196","author":"Van De Veerdonk","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.trim.2023.101798_bb0985","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1600-6143.2011.03490.x","article-title":"Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies","volume":"11","author":"Vu","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb0990","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A 5-year prospective multicenter evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb0995","series-title":"Biochem. Drug Resist","first-page":"167","article-title":"Drug resistance in ear, nose, and throat infections","author":"Ahmed","year":"2021"},{"key":"10.1016\/j.trim.2023.101798_bb1000","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1473-3099(10)70133-X","article-title":"Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study","volume":"10","author":"Kumar","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1005","article-title":"COVID-19 in transplant recipients: the Spanish experience","volume":"21","author":"Coll","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1010","first-page":"166","article-title":"Management of common infections in solid organ transplant recipients in British Columbia","volume":"64","author":"Fakhredine","year":"2022","journal-title":"B. C. Med. J."},{"key":"10.1016\/j.trim.2023.101798_bb1015","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13564","article-title":"Management of clostridioides (formerly clostridium) difficile infection (CDI) in solid organ transplant recipients: guidelines from the American society of transplantation community of practice","volume":"33","author":"Mullane","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb1020","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/TP.0b013e31824d34de","article-title":"Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipients","volume":"93","author":"Boutros","year":"2012","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb1025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/cid\/ciy171","article-title":"Bezlotoxumab for prevention of recurrent clostridium difficile infection in patients at increased risk for recurrence","volume":"67","author":"Gerding","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ajt.15058","article-title":"Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: a multicenter experience","volume":"19","author":"Cheng","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00000658-200203000-00008","article-title":"Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications","volume":"235","author":"Dallal","year":"2002","journal-title":"Ann. Surg."},{"key":"10.1016\/j.trim.2023.101798_bb1040","first-page":"426","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of america (SHEA) and the infectious diseases society of America (IDSA)","volume":"11","author":"Xu","year":"2011","journal-title":"Chin. J. Infect. Chemother."},{"key":"10.1016\/j.trim.2023.101798_bb1045","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management","volume":"27","author":"Singh","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1050","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1093\/ndt\/gfr156","article-title":"Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years","volume":"26","author":"Canet","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1055","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-6143.2009.02894.x","article-title":"Mycobacterium tuberculosis in solid organ transplant recipients","volume":"9","author":"Subramanian","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1060","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1046\/j.1523-1755.1999.00746.x","article-title":"Successful management of pulmonary tuberculosis in renal allograft recipients in a single center","volume":"56","author":"Jha","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.trim.2023.101798_bb1065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1023\/A:1025693521582","article-title":"Tuberculosis in renal transplant recipients: rifampicin sparing treatment protocol","volume":"34","author":"Vachharajani","year":"2002","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb1070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/515126","article-title":"Should prophylaxis for pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?","volume":"28","author":"Gordon","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1075","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1681\/ASN.V212s264","article-title":"Opportunistic fungal and bacterial infection in the renal transplant recipient","volume":"2","author":"Tolkoff-Rubin","year":"1992","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2023.101798_bb1080","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1128\/AAC.42.5.995","article-title":"Prevention of infection due to pneumocystis carinii","volume":"42","author":"Fishman","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.trim.2023.101798_bb1085","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12828","article-title":"The challenge of urinary tract infections in renal transplant recipients","volume":"20","author":"Hollyer","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1090","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1399-0012.2009.01129.x","article-title":"Lower risk of urinary tract infection with low-dose trimethoprim\/sulfamethoxazole compared to dapsone prophylaxis in older renal transplant patients on a rapid steroid-withdrawal immunosuppression regimen","volume":"24","author":"Giullian","year":"2010","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb1095","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.transproceed.2007.02.060","article-title":"Urinary tract infections in renal transplant recipients","volume":"39","author":"Senger","year":"2007","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2023.101798_bb1100","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13507","article-title":"Urinary tract infections in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Goldman","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb1105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.transproceed.2016.12.007","article-title":"Early removal of double-J stents decreases urinary tract infections in living donor renal transplantation: a prospective, randomized clinical trial","volume":"49","author":"Liu","year":"2017","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2023.101798_bb1110","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1111\/ajt.13829","article-title":"Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial","volume":"16","author":"Orig\u00fcen","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1115","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.transproceed.2007.10.005","article-title":"Urinary tract infections following renal transplantation: a single-center experience","volume":"39","author":"Memiko\u01e7lu","year":"2007","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2023.101798_bb1120","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13063","article-title":"Safety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: a single center, retrospective study","volume":"21","author":"Hollyer","year":"2019","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1125","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13247","article-title":"Methenamine hippurate may have particular benefit in preventing recurrent urinary tract infections in diabetic renal transplant recipients","volume":"22","author":"Quintero Cardona","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1130","series-title":"Biochem. Drug Resist","first-page":"33","article-title":"Drugs resistance in bacterial diseases","author":"Ahmed","year":"2021"},{"key":"10.1016\/j.trim.2023.101798_bb1135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/tri.12711","article-title":"Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice","volume":"29","author":"Naik","year":"2016","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2023.101798_bb1140","series-title":"Transplant. Proc., Transplant Proc","first-page":"1757","article-title":"Urinary tract infection in renal transplant recipients: Incidence, risk factors, and impact on graft function","author":"Camargo","year":"2014"},{"key":"10.1016\/j.trim.2023.101798_bb1145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics10020218","article-title":"Impact of treating asymptomatic bacteriuria in kidney transplant recipients: a prospective cohort study","volume":"10","author":"Fontser\u00e8","year":"2021","journal-title":"Antibiotics."},{"key":"10.1016\/j.trim.2023.101798_bb1150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(90)90337-D","article-title":"A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophy","volume":"89","author":"Fox","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.trim.2023.101798_bb1155","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/clinids\/4.2.614","article-title":"A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients","volume":"4","author":"Tolkoff-Rubin","year":"1982","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/14787210.4.1.137","article-title":"Pharmacological advances in the treatment of invasive candidiasis","volume":"4","author":"Deck","year":"2006","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.trim.2023.101798_bb1165","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-6143.2009.02909.x","article-title":"Candida in solid organ transplant recipients","volume":"9","author":"Pappas","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1175","article-title":"Interactions between antiinfective agents and immunosuppressants","volume":"9","author":"Thomas","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.14740\/jocmr2104w","article-title":"Fungal infections in renal transplant patients","volume":"7","author":"Khan","year":"2015","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.trim.2023.101798_bb1185","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13553","article-title":"Endemic fungal infections in solid organ transplant recipients\u2014guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Miller","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb1190","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13289","article-title":"The feared five fungal infections in kidney transplant recipients: a single-center 20-year experience","volume":"32","author":"Parajuli","year":"2018","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2023.101798_bb1195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.amjms.2019.10.008","article-title":"Risk factors associated with invasive fungal infections in kidney transplant patients","volume":"359","author":"Leitheiser","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.trim.2023.101798_bb1200","series-title":"Emerg. Transpl. Infect","first-page":"1045","article-title":"Candida infections in solid organ transplantation","author":"Barros","year":"2021"},{"key":"10.1016\/j.trim.2023.101798_bb1205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/13693780701200372","article-title":"Fungal infections in solid organ transplantation","volume":"45","author":"Silveira","year":"2007","journal-title":"Med. Mycol."},{"key":"10.1016\/j.trim.2023.101798_bb1210","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4254\/wjh.v13.i11.1653","article-title":"Fungal infections following liver transplantation","volume":"13","author":"Khalid","year":"2021","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.trim.2023.101798_bb1215","series-title":"Transplantation, Transplantation","first-page":"2023","article-title":"Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: Prospective, multicenter, case-controlled study","author":"Husain","year":"2003"},{"key":"10.1016\/j.trim.2023.101798_bb1220","article-title":"Invasive candida infections in liver transplant recipients: clinical features and risk factors for mortality","volume":"3","author":"Bassetti","year":"2017","journal-title":"Transplant. Direct."},{"key":"10.1016\/j.trim.2023.101798_bb1225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40472-020-00268-0","article-title":"Management of antimicrobial agents in abdominal organ transplant patients in intensive care unit","volume":"7","author":"Kaviani","year":"2020","journal-title":"Curr. Transplant. Rep."},{"key":"10.1016\/j.trim.2023.101798_bb1230","first-page":"216","article-title":"Candiduria in renal transplant recipients","volume":"7","author":"Hamouda","year":"2021","journal-title":"J. Kidney"},{"key":"10.1016\/j.trim.2023.101798_bb1235","first-page":"180","article-title":"Prophylaxis for latent tuberculosis infection in liver transplant recipients","volume":"3","author":"Ertu\u011frul","year":"2019","journal-title":"J. Surg. Med."},{"key":"10.1016\/j.trim.2023.101798_bb1240","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/CMR.18.1.44-69.2005","article-title":"Aspergillus infections in transplant recipients","volume":"18","author":"Singh","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.trim.2023.101798_bb1245","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/jof7121092","article-title":"Clinical and epidemiological profile of patients with invasive aspergillosis from a fourth level hospital in Bogota, Colombia: a retrospective study","volume":"7","author":"Goyeneche-Garc\u00eda","year":"2021","journal-title":"J. Fungi"},{"key":"10.1016\/j.trim.2023.101798_bb1250","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/1535370220939862","article-title":"Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors","volume":"245","author":"Li","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.trim.2023.101798_bb1255","first-page":"112","article-title":"Critical care issues in adult liver transplantation","volume":"13","author":"Gopal","year":"2009","journal-title":"Indian J. Crit. Care Med."},{"key":"10.1016\/j.trim.2023.101798_bb1260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof6040381","article-title":"Update on respiratory fungal infections in cystic fibrosis lung disease and after lung transplantation","volume":"6","author":"Renner","year":"2020","journal-title":"J. Fungi"},{"key":"10.1016\/j.trim.2023.101798_bb1265","series-title":"Biochem. Drug Resist","first-page":"143","article-title":"Antifungal drugs: Mechanism of action and resistance","author":"Ahmed","year":"2021"},{"key":"10.1016\/j.trim.2023.101798_bb1270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40472-022-00363-4","article-title":"Fungal infections in lung transplantation","volume":"9","author":"Ramirez-Sanchez","year":"2022","journal-title":"Curr. Transplant. Rep."},{"key":"10.1016\/j.trim.2023.101798_bb1275","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.21037\/jtd-2021-26","article-title":"Fungal infections in lung transplantation","volume":"13","author":"Samanta","year":"2021","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1280","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JCM.41.8.3623-3626.2003","article-title":"Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi","volume":"41","author":"Diekema","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.trim.2023.101798_bb1285","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/pathogens11060699","article-title":"Cryptococcal meningitis in kidney transplant recipients: a two-decade cohort study in France","volume":"11","author":"Tardieu","year":"2022","journal-title":"Pathogens."},{"key":"10.1016\/j.trim.2023.101798_bb1290","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/ajt.12116","article-title":"Cryptococcosis in solid organ transplantation","volume":"13","author":"Baddley","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jlb.55.1.35","article-title":"The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection","volume":"55","author":"Huffnagle","year":"1994","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.trim.2023.101798_bb1300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12281-016-0256-3","article-title":"Evolution of Cryptococcal antigen testing: what is new?","volume":"10","author":"Nalintya","year":"2016","journal-title":"Curr. Fungal Infect. Rep."},{"key":"10.1016\/j.trim.2023.101798_bb1305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof6030103","article-title":"In vitro interaction between isavuconazole and tacrolimus, cyclosporin a, or sirolimus against aspergillus species","volume":"6","author":"Schwarz","year":"2020","journal-title":"J. Fungi"},{"key":"10.1016\/j.trim.2023.101798_bb1310","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3389\/fmicb.2019.02082","article-title":"Short-course rather than low-dose amphotericin B may exert potential influence on mortality in Cryptococcal meningitis patients treated with amphotericin B plus flucytosine alone or in combination with fluconazole","volume":"10","author":"Xu","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.trim.2023.101798_bb1315","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.idc.2018.04.007","article-title":"Endemic mycoses in solid organ transplant recipients","volume":"32","author":"Nel","year":"2018","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.trim.2023.101798_bb1320","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13142","article-title":"Evaluation of infectious risk and outcomes in the hmong renal transplant population","volume":"21","author":"Jorgenson","year":"2019","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1325","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13365","article-title":"Simultaneous coccidioidomycosis and phaeohyphomycosis in a kidney transplant recipient: a case report and literature review","volume":"22","author":"Puing","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2023.101798_bb1330","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s40472-020-00305-y","article-title":"General approach to the clinical care of solid organ transplant recipients with COVID-19 infection: management for transplant recipients","volume":"7","author":"Kim","year":"2020","journal-title":"Curr. Transplant. Rep."},{"key":"10.1016\/j.trim.2023.101798_bb1335","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40472-021-00322-5","article-title":"Immune responses to SARS-CoV-2 in solid organ transplant recipients","volume":"8","author":"Phadke","year":"2021","journal-title":"Curr. Transplant. Rep."},{"key":"10.1016\/j.trim.2023.101798_bb1340","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000491439","article-title":"Complement and bacterial infections: from molecular mechanisms to therapeutic applications","volume":"10","author":"Heesterbeek","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.trim.2023.101798_bb1345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/pathogens5010031","article-title":"The T cell response to Staphylococcus aureus","volume":"5","author":"Br\u00f6ker","year":"2016","journal-title":"Pathogens."},{"key":"10.1016\/j.trim.2023.101798_bb1350","first-page":"1","article-title":"Immune responses to bacteria","author":"Laing","year":"2018","journal-title":"Br. Soc. Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb1355","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127569","article-title":"Skin-restricted commensal colonization accelerates skin graft rejection","volume":"4","author":"Lei","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.trim.2023.101798_bb1360","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.molmed.2012.09.005","article-title":"Immune responses to Clostridium difficile infection","volume":"18","author":"Madan","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.trim.2023.101798_bb1365","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fped.2019.00350","article-title":"Immune response to mycobacterium tuberculosis: a narrative review","volume":"7","author":"de Martino","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.trim.2023.101798_bb1370","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mib.2017.10.019","article-title":"New advances in understanding the host immune response to pneumocystis","volume":"40","author":"Hoving","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.trim.2023.101798_bb1375","first-page":"1","article-title":"Antifungal immune responses: emerging host-pathogen interactions and translational implications","volume":"10","author":"Kumar","year":"2018","journal-title":"Genom. Med."},{"key":"10.1016\/j.trim.2023.101798_bb1380","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.aao1503","article-title":"CX3CR1+, mononuclear phagocytes control immunity to intestinal fungi","volume":"359","author":"Leonardi","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.trim.2023.101798_bb1385","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/mi.2016.52","article-title":"Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis","volume":"10","author":"Zelante","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb1390","doi-asserted-by":"crossref","first-page":"eaan5357","DOI":"10.1126\/sciimmunol.aan5357","article-title":"Type III interferon is a critical regulator of innate antifungal immunity","volume":"2","author":"Espinosa","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb1395","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.coi.2008.03.007","article-title":"Cytotoxic human CD4+ T cells","volume":"20","author":"van de Berg","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb1400","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-065X.2011.01073.x","article-title":"Control of antiviral immunity by pattern recognition and the microbiome","volume":"245","author":"Pang","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.trim.2023.101798_bb1405","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/01.tp.0000230432.39447.8b","article-title":"Reactivation of viruses in solid organ transplant patients receiving cytomegalovirus prophylaxis","author":"Humar","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2023.101798_bb1410","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41579-021-00582-z","article-title":"Pathogenesis of human cytomegalovirus in the immunocompromised host","volume":"19","author":"Griffiths","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.trim.2023.101798_bb1415","doi-asserted-by":"crossref","first-page":"323","DOI":"10.23876\/j.krcp.18.0063","article-title":"Common viral infections in kidney transplant recipients","volume":"37","author":"Vanichanan","year":"2018","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.trim.2023.101798_bb1420","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/TP.0000000000003480","article-title":"Biomarkers of cytokine release syndrome predict disease severity and mortality from COVID-19 in kidney transplant recipients","volume":"105","author":"Benotmane","year":"2021","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb1425","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/TP.0000000000003460","article-title":"COVID-19 in solid organ transplantation: a matched retrospective cohort study and evaluation of immunosuppression management","volume":"105","author":"Miarons","year":"2021","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb1430","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1111\/ajt.16431","article-title":"Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: a retrospective cohort","volume":"21","author":"Avery","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1435","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/TP.0000000000003447","article-title":"COVID-19 outcomes among solid organ transplant recipients: a case-control study","volume":"105","author":"Sharma","year":"2021","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb1440","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/ajt.16280","article-title":"Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States","volume":"20","author":"Molnar","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1445","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1111\/ajt.16185","article-title":"COVID-19 and kidney transplantation: results from the TANGO international transplant consortium","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1450","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1111\/ajt.16261","article-title":"Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients","volume":"20","author":"Hartzell","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1455","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/ajt.16348","article-title":"T cell and antibody responses to SARS-CoV-2: experience from a French transplantation and hemodialysis center during the COVID-19 pandemic","volume":"21","author":"Candon","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2023.101798_bb1460","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3748\/wjg.v28.i9.881","article-title":"Innate and adaptive immune escape mechanisms of hepatitis B virus","volume":"28","author":"Zhao","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.trim.2023.101798_bb1465","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/transplantology3010003","article-title":"Innate immunity response to BK virus infection in polyomavirus-associated nephropathy in kidney transplant recipients","volume":"3","author":"Chancharoenthana","year":"2022","journal-title":"Transplantology."},{"key":"10.1016\/j.trim.2023.101798_bb1470","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000001095","article-title":"The immunology of posttransplant CMV infection: potential effect of CMV immunoglobulins on distinct components of the immune response to CMV","volume":"100","author":"Carbone","year":"2016","journal-title":"Transplantation."},{"key":"10.1016\/j.trim.2023.101798_bb1475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/immadv\/ltaa007","article-title":"Recent advances in immunotherapies against infectious diseases","volume":"1","author":"Ramamurthy","year":"2021","journal-title":"Immunother. Adv."},{"key":"10.1016\/j.trim.2023.101798_bb1480","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3389\/fimmu.2019.02631","article-title":"Heterologous immunity: role in natural and vaccine-induced resistance to infections","volume":"10","author":"Agrawal","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2023.101798_bb1485","first-page":"1","article-title":"Emerging new therapeutic antibody derivatives for cancer treatment","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trim.2023.101798_bb1490","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/cancers11111756","article-title":"Targeting negative and positive immune checkpoints with monoclonal antibodies in therapy of cancer","volume":"11","author":"Marhelava","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trim.2023.101798_bb1495","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ajh.25418","article-title":"An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer","volume":"94","author":"Feins","year":"2019","journal-title":"Am. J. Hematol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423000151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423000151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:02:42Z","timestamp":1760810562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327423000151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":299,"alternative-id":["S0966327423000151"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101798","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections after organ transplantation and immune response","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101798"}}